Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 6,622

Document Document Title
WO/2017/069561A1
The present invention relates to a method for selectively producing ginsenoside F2, compound Mc, and compound O, which is originally present in ginseng in trace amounts, from saponins of ginseng and, more specifically, to a method capabl...  
WO/2017/069569A1
The present invention relates to a method for selectively producing compound K and compound Y, which are originally present in trace amounts in ginseng, from saponins of ginseng and, more specifically, to a method capable of obtaining de...  
WO/2017/057851A1
The present invention relates to a ginsenoside fatty acid ester compound, a method for preparing same, and a cosmetic composition comprising same and, more specifically, to a ginsenoside fatty acid ester compound, modified into a fatty a...  
WO/2017/055502A1
The invention relates to an improved process for the preparation of selamectin of formula 5.  
WO/2017/057460A1
Provided is a method for producing an organic compound, wherein the organic compound is an industrially useful compound, and a deodorization step, for removing from a reaction solution odorants that are generated in or remaining after a ...  
WO/2017/057852A1
The present invention relates to a ginsenoside fatty acid ester compound, a method for preparing same, and a cosmetic composition comprising same and, more specifically, to a ginsenoside fatty acid ester compound, modified into a fatty a...  
WO/2017/057461A1
A production method for producing an aldehyde compound or a ketone compound by oxidizing a primary or secondary alcohol compound, wherein the alcohol compound has, in the molecule thereof, a group selected from an amino group, an azide g...  
WO/2017/058953A1
Disclosed herein, inter alia, are compounds, compositions, and methods of use thereof in the sequencing a nucleic acid.  
WO/2017/050032A1
A ketolide antibiotics intermediate, a preparation method therefor, and application thereof in preparation of solithromycin. The ketolide antibiotics intermediate has a compound structural general formula as shown as follows, and can be ...  
WO/2017/040769A1
Compositions and methods for the production of derivatives of spinosyns are provided. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and/or nematodes and are useful in the agricultural and anim...  
WO/2017/040763A1
Compositions including derivatives of spinosyns and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include spinosyn derivatives functionalized on the C5-C6 double bond of th...  
WO/2017/040878A1
Compositions including derivatives of spinosyns and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include those functionalized on the C-13,14 double bond to provide an addi...  
WO/2017/040882A1
Compositions including derivatives of spinosyns and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include spinosyn derivatives functionalized on the C5-C6 double bond of sp...  
WO/2017/028766A1
Disclosed are a method for preparing a taxane derivative of formula 2, and a compound of formula 1 which is used as a raw material or intermediate for preparing the taxane derivative of formula 2.  
WO/2016/192829A8
The present invention relates to feed media comprising deep eutectic solvents and/or ionic liquids.  
WO/2017/013637A1
Provided herein are alpha2-selective Na,K-ATPase inhibitors, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and hea...  
WO/2017/013648A1
Provided herein are alpha2- selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in tre...  
WO/2016/100833A3
In one aspect, the present invention provides novel derivatives of trioxacarin analogs of the formula (I) wherein the variables are as defined herein. The application also provides compositions, methods of treatment, and methods of synth...  
WO/2016/204493A1
The present invention relates to a novel (1aS,1bS,2S,4S,5aR,6S,6aS)-1a-(hydroxymethyl)-4-methoxy-2-(( (2S,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2 H-pyran-2-yl)oxy)octahydrooxireno[2',3':4,5]cyclopenta[1,2-c ]pyran-6-yl 4...  
WO/2016/198485A1
The present invention relates to compounds according to general formula (I) with enhanced absorption of UV-B irradiation. The present invention also relates to an UV-B tolerant plant and a method for enhanced production of compounds acco...  
WO/2016/197980A1
The present invention relates to the technical field of pharmaceutical chemistry, especially to Baicalin crystal form A, and preparation method and application thereof. The crystal form shows characteristic peaks at X-ray powder diffract...  
WO/2016/192829A1
The present invention relates to feed media comprising deep eutectic solvents and/or ionic liquids.  
WO/2016/192830A1
The present invention relates to cell culture media compositions comprising deep eutectic solvents and/or ionic liquids.  
WO/2016/183905A1
An icarisid compound shown in Formula I. The compound is a natural chemical component of a traditional Chinese medicine (epimedium herb) or a chemically modified product or a totally synthetic product based on these natural products. The...  
WO/2016/180818A1
The present invention relates to glycosylating polyphenols via biocatalysis. More specifically the present invention discloses particular mutants of the thermostable sucrose phosphorylase derived from the microorganism Thermoanaerobacter...  
WO/2016/168568A1
Disclosed are derivatives of amphotericin B (AmB) characterized by improved therapeutic index compared to AmB. The AmB derivatives include C16 ureas, carbamates, and amides according to Formula (I); C3' -substituted C16 ureas, carbamates...  
WO/2016/154533A1
The present invention provides desosamine and mycaminose analogs and nitro sugars and methods for their preparation. The invention also provides methods of cyclizing a compound of Formula (Α') with glyoxal to give a nitro sugar of Formu...  
WO/2016/144833A1
Processes and intermediates for preparing fluoroketolide compounds are described herein.  
WO/2013/167995A3
The invention relates to the compounds of formula (I) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof The pharmaceutical compositions comprising an effective amount...  
WO/2016/128401A1
The present invention relates to compounds of general formula (I), wherein R1, R2 and (A) take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of ...  
WO/2016/124585A1
The present invention relates to a process for the preparation of diosmin from hesperidin. The process involves the oxidation of acylated hesperidin with iodine or bromine in a C2-C4 carboxylic acid medium and subsequent treatment with a...  
WO/2016/112317A1
The present invention pertains to prevention of and/or treatment for filariasis. In particular, the present invention pertains to the use of tylosin A and its analogs and derivatives to prevent or treat filarial worm infection and/or dis...  
WO/2016/074221A1
Provided are a spinosad heterologous expression strain construction method, a spinosad heterologous expression strain obtained by the method and use thereof in preparing the spinosad heterologous expression strain. The method utilizes a ...  
WO/2016/073756A1
The present invention provides nucleoside phosphoramidate compounds of Formula (I), where R1, R2a, R2b, R4, R5a, R5b, Rb5, Rb6 and D are as defined herein. The invention further includes pharmaceutical compositions comprising a compound ...  
WO/2016/073972A1
A method of treating cancer in a subject in need thereof is described that includes administering a therapeutically effective amount of a virus or virus-like particle to the subject, wherein the virus particle is nonreplicating and nonin...  
WO/2016/070849A1
Provided in the present invention are a class of Lincomycin biosynthetic intermediates and a preparation method and use thereof. Specifically provided are Lincomycin biosynthetic intermediates obtained from the genetic modification of a ...  
WO/2016/063896A1
Provided is an ascorbic acid derivative that can be used to obtain a glycoside of which ascorbic acid is the aglycone. The abovementioned derivative is the compound represented by formula (A) (i.e., 2,3,6-tri-O-acyl-ascorbic acid). (In t...  
WO/2016/064007A1
The present invention relates to: a method for producing rubusoside from stevioside by using a Lactobacillus plantarum strain, which is a type of Lactobacillus; a composition, to be used in the method, for producing rubusoside, containin...  
WO/2016/056648A1
The present invention addresses the problem of providing a simple and versatile method for stabilizing 2-O-α-D-glucosyl-L-ascorbic acid in an acidic aqueous medium. The problem is solved by providing a method for stabilizing 2-O-α-D-gl...  
WO/2016/041195A1
Disclosed is a class of flavone glycoside derivatives, compounds of structural general formula (I) described below or pharmaceutically acceptable salts or hydrates thereof, comprising racemates, optical isomers and epimers thereof. Also ...  
WO/2016/040779A1
Disclosed are urea derivatives of polyene macrolide antibiotics, other than amphotericin B, comprising a urea-containing substructure represented by wherein R represents hydrogen, alkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, aminoalk...  
WO/2016/028233A1
The present invention provides a method for determining the presence of a microorganism in a sample using an electrochemically active reporter, wherein the method comprises (a) contacting the sample with an electrochemically active repor...  
WO/2016/027755A1
A compound of the following formula [1], which possesses good antimicrobial activity against erythromycin-resistant bacteria, such as resistant pneumococci, streptococci and mycoplasma, against which conventional macrolide antibiotics do...  
WO/2016/019682A1
The present invention relates to a chemical synthesis method for phillyrin. The method of the present invention comprises: first dissolving a glycosyl acceptor, phillygenin and a glycosyl donor in an organic solvent and conducting glycos...  
WO/2016/014779A1
Provided are antifungal C2'-epi-polyene macrolides with dramatically improved therapeutic index compared to corresponding mycosamine-bearing polyene macrolides. Also provided are methods for making the antifungal C2'-epi-polyene macrolid...  
WO/2016/004848A1
A fidaxomicin purification method, comprising: fermenting Actinoplanes sp. HS-16-20 to generate fermented liquid; conducting solid/liquid separation on the fermented liquid, soaking mycelium in an organic solvent, and filtering to obtain...  
WO/2016/005049A1
The present invention relates to a compound according to general formula (I), which exhibits bioactivity; methods for the production of the compound; to pharmaceutical compositions comprising one or more of the compound(s); and to the us...  
WO/2015/190587A1
Provided is an amphotericin B derivative represented by formula (I). [In formula (I), each symbol is as defined in the description.] The aforesaid compound, which is characterized by having a urea structure, cyclic structure, hydroxyalky...  
WO/2015/003082A3
The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus.  
WO/2015/175875A1
Disclosed is a derivative of amphotericin B (AmB), denoted C2'epiAmB, with an improved therapeutic index over amphotericin B, pharmaceutical compositions comprising the AmB derivative, methods of making the AmB derivative and the pharmac...  

Matches 151 - 200 out of 6,622